Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Caprylohydroxamic Acid
2. Octanohydroxamic Acid
3. Octanohydroxamic Acid, 3h-labeled Cpd
4. Taselin
1. Octanohydroxamic Acid
2. 7377-03-9
3. Caprylohydroxamic Acid
4. Octanamide, N-hydroxy-
5. Taselin
6. Caprylhydroxamic Acid
7. Octanoylhydroxamic Acid
8. Caprylohydroxamate
9. Upy805k99w
10. Mfcd00143918
11. Octanohydroxamsaeure
12. Octanehydroxamic Acid
13. Einecs 230-936-7
14. Carpylohydroxamic Acid
15. Brn 1703666
16. Octanoic Acid Hydroxyamide
17. N-hydroxy-octanamide
18. Unii-upy805k99w
19. Schembl572646
20. N-hydroxyoctanamide, Aldrichcpr
21. Dtxsid8074609
22. Rguvupqqfxcjfc-uhfffaoysa-
23. Octanohydroxamic Acid [mi]
24. Caprylhydroxamic Acid [inci]
25. Zinc95740180
26. Akos009158157
27. Cs-w001857
28. As-20087
29. Sy020160
30. Db-029564
31. C1232
32. Ft-0660306
33. Ft-0695202
34. A920270
35. J-523591
36. Q27291194
| Molecular Weight | 159.23 g/mol |
|---|---|
| Molecular Formula | C8H17NO2 |
| XLogP3 | 1.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 6 |
| Exact Mass | 159.125928785 g/mol |
| Monoisotopic Mass | 159.125928785 g/mol |
| Topological Polar Surface Area | 49.3 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 104 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
98
PharmaCompass offers a list of N-Hydroxyoctanamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right N-Hydroxyoctanamide manufacturer or N-Hydroxyoctanamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred N-Hydroxyoctanamide manufacturer or N-Hydroxyoctanamide supplier.
PharmaCompass also assists you with knowing the N-Hydroxyoctanamide API Price utilized in the formulation of products. N-Hydroxyoctanamide API Price is not always fixed or binding as the N-Hydroxyoctanamide Price is obtained through a variety of data sources. The N-Hydroxyoctanamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N-Hydroxyoctanamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Hydroxyoctanamide, including repackagers and relabelers. The FDA regulates N-Hydroxyoctanamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Hydroxyoctanamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Hydroxyoctanamide supplier is an individual or a company that provides N-Hydroxyoctanamide active pharmaceutical ingredient (API) or N-Hydroxyoctanamide finished formulations upon request. The N-Hydroxyoctanamide suppliers may include N-Hydroxyoctanamide API manufacturers, exporters, distributors and traders.
N-Hydroxyoctanamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Hydroxyoctanamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-Hydroxyoctanamide GMP manufacturer or N-Hydroxyoctanamide GMP API supplier for your needs.
A N-Hydroxyoctanamide CoA (Certificate of Analysis) is a formal document that attests to N-Hydroxyoctanamide's compliance with N-Hydroxyoctanamide specifications and serves as a tool for batch-level quality control.
N-Hydroxyoctanamide CoA mostly includes findings from lab analyses of a specific batch. For each N-Hydroxyoctanamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Hydroxyoctanamide may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Hydroxyoctanamide EP), N-Hydroxyoctanamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Hydroxyoctanamide USP).
